A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
OncoC4, Inc.
Sotio Biotech Inc.
National Cancer Institute (NCI)
ViroMissile, Inc.
St. Jude Children's Research Hospital
Jonsson Comprehensive Cancer Center
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
M.D. Anderson Cancer Center
Degron Therapeutics Co.
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
West China Hospital
HiFiBiO Therapeutics
Chiome Bioscience Inc.
Pfizer
University of Virginia
Incyte Corporation
Incyte Corporation
Vincerx Pharma, Inc.
Molecular Templates, Inc.
National Cancer Institute (NCI)
Xencor, Inc.
Pliant Therapeutics, Inc.
BioEclipse Therapeutics
Atreca, Inc.
University of Florida
Fate Therapeutics
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Provectus Pharmaceuticals
AbbVie
Pfizer
AbbVie
Fate Therapeutics
Incyte Corporation
Incyte Corporation
Polaris Group
Abramson Cancer Center at Penn Medicine
Sichuan Huiyang Life Science and Technology Corporation
AbbVie
Roswell Park Cancer Institute
Mirna Therapeutics, Inc.
Rutgers, The State University of New Jersey
City of Hope Medical Center
National Cancer Institute (NCI)
Angiochem Inc